The importance of Bordetella pertussis strains which do not produce virulence factors in the epidemiology of pertussis
- PMID: 28513461
- DOI: 10.5604/01.3001.0010.3821
The importance of Bordetella pertussis strains which do not produce virulence factors in the epidemiology of pertussis
Abstract
Bordetella pertussis strains, which have lost the ability to produce antigens, such as pertactin - Prn, pertussis toxin - Ptx, filamentous haemagglutinin - FHA, fimbriae type 2 and 3 - Fim 2 and 3, tracheal colonization factor - TcfA, have recently been isolated in countries with a high vaccination coverage. The emergence of such isolates might have resulted from B. pertussis natural evolution course or adaptive mechanisms, allowing increased circulation of the pathogen in vaccinated populations. So far, the majority of described mutants were deficient in the Prn production. Prn deficient isolates were found in countries which use acellular pertussis vaccines (aP) in routine immunization programmes. The increase of frequency of Prn¯ strains isolation was correlated with the period of routine vaccination with aP vaccines. In most countries, the spread of these isolates has resulted from independent mutations rather than from the expansion of a single clone. Prn¯ isolates were collected from patients showing typical clinical symptoms of pertussis found for Prn+ strains. Results of in vitro and in vivo studies have shown that Prn¯, Ptx¯ and FHA¯ isolates retain cytotoxic properties, and besides Ptx¯ isolates, were lethal in intranasally infected mice. Further explanation of the impact of antigen deficiencies on virulence and transmission of B. pertussis in the context of the continuous increase of pertussis incidence is necessary to develop a new, optimized strategy of pertussis prevention.
Similar articles
-
Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015.Euro Surveill. 2019 Feb;24(7):1700832. doi: 10.2807/1560-7917.ES.2019.24.7.1700832. Euro Surveill. 2019. PMID: 30782265 Free PMC article.
-
Evolution of Bordetella pertussis over a 23-year period in France, 1996 to 2018.Euro Surveill. 2021 Sep;26(37):2001213. doi: 10.2807/1560-7917.ES.2021.26.37.2001213. Euro Surveill. 2021. PMID: 34533118 Free PMC article.
-
Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination.Microbes Infect. 2019 Apr-May;21(3-4):170-175. doi: 10.1016/j.micinf.2018.12.001. Epub 2018 Dec 21. Microbes Infect. 2019. PMID: 30580013
-
Acellular pertussis vaccines and the role of pertactin and fimbriae.Expert Rev Vaccines. 2007 Feb;6(1):47-56. doi: 10.1586/14760584.6.1.47. Expert Rev Vaccines. 2007. PMID: 17280478 Review.
-
Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.Expert Rev Vaccines. 2014 Sep;13(9):1135-46. doi: 10.1586/14760584.2014.932254. Epub 2014 Jun 23. Expert Rev Vaccines. 2014. PMID: 24953157 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical